Intrinsic Value Partners, LLC Moderna, Inc. Transaction History

Intrinsic Value Partners, LLC

$109 Million
Q2 2025

A detailed history of Intrinsic Value Partners, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Intrinsic Value Partners, LLC holds 28,791 shares of MRNA stock, worth $983,212. This represents 0.73% of its overall portfolio holdings.

Number of Shares

28,791

Previous 36,211 20.49%

Holding current value

$983,212

Previous $1.03 Million 22.61%

% of portfolio

0.73%

Previous 1.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 21, 2025	SELL	$23.65 - $28.54 $175,483 - $211,766	-7,420 Reduced 20.49%	28,791 $794,000
Q1 2025 May 08, 2025	SELL	$28.35 - $47.53 $1,247 - $2,091	-44 Reduced 0.12%	36,211 $1.03 Million
Q4 2024 Jan 30, 2025	SELL	$36.85 - $63.93 $557,798 - $967,708	-15,137 Reduced 29.45%	36,255 $1.51 Million
Q3 2024 Nov 04, 2024	BUY	$63.64 - $125.14 $1.56 Million - $3.07 Million	24,505 Added 91.14%	51,392 $3.43 Million
Q2 2024 Jul 25, 2024	SELL	$101.21 - $166.61 $2,530 - $4,165	-25 Reduced 0.09%	26,887 $3.19 Million
Q1 2024 Apr 22, 2024	SELL	$85.37 - $115.44 $39,184 - $52,986	-459 Reduced 1.68%	26,912 $2.87 Million
Q4 2023 Feb 07, 2024	BUY	$69.51 - $104.43 $469,887 - $705,946	6,760 Added 32.8%	27,371 $2.72 Million
Q3 2023 Oct 17, 2023	BUY	$96.41 - $126.61 $539,896 - $709,016	5,600 Added 37.31%	20,611 $2.13 Million
Q2 2023 Aug 02, 2023	BUY	$118.5 - $160.53 $361,543 - $489,777	3,051 Added 25.51%	15,011 $1.82 Million
Q1 2023 Apr 18, 2023	SELL	$135.66 - $197.02 $75,969 - $110,331	-560 Reduced 4.47%	11,960 $1.84 Million
Q4 2022 Jan 12, 2023	SELL	$118.38 - $210.04 $157,445 - $279,353	-1,330 Reduced 9.6%	12,520 $2.25 Million
Q3 2022 Oct 13, 2022	BUY	$118.07 - $194.18 $438,630 - $721,378	3,715 Added 36.66%	13,850 $1.64 Million
Q2 2022 Jul 18, 2022	BUY	$117.13 - $176.59 $1.19 Million - $1.79 Million	10,135 New	10,135 $1.45 Million

Others Institutions Holding MRNA

# of Institutions

863

Shares Held

255M

Call Options Held

24M

Put Options Held

31.3M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $13.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrinsic Value Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrinsic Value Partners, LLC with notifications on news.

Account

Intrinsic Value Partners, LLC Moderna, Inc. Transaction History